Doximity, Inc.
NYSE:DOCSMedical - Healthcare Information Services
-$0.09 today
- Market cap
- $5.47B
- Beta
- 1.29
- P/E (TTM)
- 19.2
- EPS (TTM)
- $1.06
Volume 2.27M
Average 3.89M
DOCS Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Doximity, Inc.NYSE: DOCS
Net Income · Q2 FY2027 · quarter ended Sep 2026
Net income declines year over year
Q2 FY2027 net income of $34.73M fell 44.0% year over year, ahead of the -44.8% change in trailing-twelve-month net income. Sequentially, it rose 42.8% from the prior quarter. Over 3 fiscal years it compounded at +20.2% a year.
Context
- Net income amounted to 30.4% of revenue in FY2026, down 8.7 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 15 analysts of $253.97M (+29.5%) for the fiscal year ending Mar 2027, a step up from the -12.2% reported in FY2026.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterSep 2026
- $34.73M+42.8% QoQ
- Last fiscal yearMar 2026
- $196.05M-12.2% YoY
- LTMSep 2026
- $139.72M-44.8% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -44.0% | +34.8% | +78.8 pp |
| 1 year | -12.2% | +29.5% | +41.7 pp |
| 3-year CAGR | +20.2% | +17.5% | -2.7 pp |
| 5-year CAGR | +15.8% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2026
- 196.05M USD
- Year-over-year change
- -12.2%
- 4-year CAGR
- +6.1%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 196.05M | -12.2% |
| FY2025 | 2025-03-31 | 223.19M | +51.2% |
| FY2024 | 2024-03-31 | 147.58M | +30.8% |
| FY2023 | 2023-03-31 | 112.82M | -27.1% |
| FY2022 | 2022-03-31 | 154.78M | — |
Net Income vs competitors
How DOCS compares with its peers on the latest reported figures
- DOCS's LTM Sep 2026 net income of $139.72M is the 8th largest of the 10 companies compared; the peer median is $236.49M.
- Its year-over-year change of -44.8% is the 6th highest of 10, against a peer median of -14.2%.
- Net income amounts to 21.1% of revenue for DOCS, versus a peer median of 8.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.43B | +277.4% | +5.0% | 17.3% | |
| LTM Jun 2026 | $776.3M | +12.0% | +15.7% | 12.5% | |
| LTM Sep 2026 | $485.07M | +21.6% | -14.0% | 37.9% | |
| LTM Jun 2026 | $410.7M | -88.2% | — | 2.8% | |
| LTM Jun 2026 | $248.21M | -68.7% | -23.2% | 3.0% | |
| LTM Jul 2026 | $239.22M | -14.2% | -22.2% | 8.2% | |
| LTM Jul 2026 | $236.49M | +62.2% | — | 17.4% | |
| LTM Sep 2026 | $139.72M | -44.8% | +20.2% | 21.1% | |
| LTM Sep 2026 | $54.17M | -73.4% | -5.4% | 3.6% | |
| LTM Jul 2026 | $45.4M | -111.1% | -1.0% | 1.1% | |
| Peer median (excluding DOCS) | $236.49M | -14.2% | -5.4% | 8.2% | |
Competitors are the stored peer set for DOCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2022 Mar 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Net Income | 154.78M | 112.82M | 147.58M | 223.19M | 196.05M |
| Depreciation & Amortization | 5.04M | 10.28M | 10.27M | 10.66M | 14.38M |
| Deferred Income Tax | (41.25M) | 13.23M | (8.59M) | (11.59M) | 32.14M |
| Stock-Based Compensation | 31.44M | 47.83M | 51.08M | 72.39M | 121.63M |
| Change in Working Capital | (40.33M) | (21.03M) | (24.52M) | (24.1M) | (45.7M) |
| Accounts Receivables | (31.02M) | (26.24M) | 3.99M | (27.21M) | (16.88M) |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 8.66M | (195K) | 8.33M | (663K) | 4.27M |
| Other Working Capital | (17.98M) | 5.4M | (36.85M) | 3.77M | (33.09M) |
| Other Non-Cash Items | 16.89M | 16.47M | 8.29M | 2.72M | 7.96M |
| Operating Cash Flow | 126.58M | 179.6M | 184.1M | 273.27M | 326.46M |
| Capital Expenditures | (5.7M) | (6.18M) | (5.8M) | (6.53M) | (8.96M) |
| Acquisitions (Net) | 0 | (53.5M) | 0 | 0 | (26.53M) |
| Purchases of Investments | (1.32B) | (190.56M) | (472.87M) | (675.56M) | (389.16M) |
| Sales of Investments | 681.72M | 190.32M | 509.85M | 652.78M | 571.82M |
| Other Investing Activities | 595K | 0 | (5.65M) | 0 | 0 |
| Investing Cash Flow | (640.57M) | (59.92M) | 31.19M | (29.3M) | 147.17M |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 553.91M | 0 | 0 | 23.3M | 13.68M |
| Common Stock Repurchased | (2.7M) | (85.32M) | (280.72M) | (120.29M) | (431.65M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 9.21M | 10.86M | 4.19M | (34.15M) | (46.09M) |
| Financing Cash Flow | 560.42M | (74.46M) | (276.52M) | (131.14M) | (464.06M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 46.42M | 45.22M | (61.24M) | 112.83M | 9.56M |
| Free Cash Flow | 120.88M | 173.42M | 178.3M | 266.74M | 317.5M |
Doximity, Inc.
NYSE:DOCS
Intrinsic Alpha fair value
Locked
Current Price
$30.67
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.